Please login to the form below

Not currently logged in
Email:
Password:

Eisenmenger syndrome

This page shows the latest Eisenmenger syndrome news and features for those working in and with pharma, biotech and healthcare.

Actelion reports late-stage trial failure as J&J talks continue

Actelion reports late-stage trial failure as J&J talks continue

Actelion has revealed that a late-stage trial of Opsumit in patients with Eisenmenger syndrome failed to meet its objectives, just as it is immersed in takeover talks with Johnson &Johnson ... MAESTRO involved 266 patients with pulmonary artery

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics